Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q3 2022
Institutional positions in Aspire Biopharma Holdings, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- 0 vs. Q2 2022
- Shares held
- 9.12M
- +674.6K (+8.0%) vs. Q2 2022
- Total value
- $1.28M
- −$101.6K (−7.4%) vs. Q2 2022
- New holders
- 5
- 4 more added
- Sold out
- 5
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 5 | $0 | 0.00% | −24,995−100.0% | Reduced |
| Investors Research Corp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 12,500 | $1.00K | 0.00% | −12,500−50.0% | Reduced |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 12,500 | $1.00K | 0.00% | +12,500 | New |
| Bulldog Investors, LLP | 12,500 | $1.00K | 0.00% | +12,500 | New |
| Kohlberg Kravis Roberts & Co. L.P. | 25,273 | $3.00K | 0.00% | −12,227−32.6% | Reduced |
| Mint Tower Capital Management B.V. | 25,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| CVI Holdings, LLC | 25,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 44,594 | $5.00K | 0.00% | +44,594 | New |
| Basso Capital Management, L.P. | 50,400 | $6.00K | 0.00% | +50,400 | New |
| Caas Capital Management LP | 75,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Difesa Capital Management, LP | 75,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 75,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Atalaya Capital Management LP | 50,000 | $9.00K | 0.00% | +50,000 | New |
| Whitebox Advisors LLC | 125,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $15.0K | 0.00% | 00.0% | Unchanged |
| Kim, LLC | 100,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 147,051 | $16.0K | 0.00% | +133,230+964.0% | Added |
| Sage Rock Capital Management LP | 160,076 | $18.0K | 0.00% | −23,571−12.8% | Reduced |
| Context Capital Management, LLC | 175,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 150,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 200,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Magnetar Financial LLC | 199,000 | $29.0K | 0.00% | +178,750+882.7% | Added |
| D. E. Shaw & Co., Inc. | 199,999 | $34.0K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $36.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 350,000 | $39.0K | 0.00% | 00.0% | Unchanged |
| Kepos Capital LP | 350,000 | $39.0K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $44.0K | 0.00% | −4,327−1.1% | Reduced |
| Verition Fund Management LLC | 432,757 | $48.0K | 0.00% | −7,964−1.8% | Reduced |
| Sculptor Capital LP | 500,000 | $73.0K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 669,998 | $74.0K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $116.0K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 938,600 | $120.0K | 0.00% | +570,000+154.6% | Added |
| Linden Advisors LP | 899,999 | $131.0K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $143.0K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $151.0K | 0.00% | – | – |
| Radcliffe Capital Management, L.P. | 163,800 | – | – | +13,800+9.2% | Added |
| Woodline Partners LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −97,474−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −66,199−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −23,571−100.0% | Sold out |
| Cohanzick Management, LLC | 0 | $0 | 0.00% | −18,383−100.0% | Sold out |